The 100 best performing ASX stocks in FY20

Link copied to
clipboard

The average ASX stock returned 13 per cent last financial year but the 100 best performing stocks returned an average of 394 per cent.

Stockhead has compiled a list (see below) of the 100 best performing ASX stocks based on share price returns for the year to June 30, 2020.

We have not used a market cap cut off because it would exclude many of the year’s success stories which saw former small caps go big.

During the year, the ASX broadly copped a big hit due to COVID-19, particularly during February and March. But many of the best performing stocks thrived despite the pandemic or in some cases because of it.

Here are FY20’s 100 best performing ASX small caps:

Scroll or swipe to reveal full table. Click headings to sort

The best performing sectors

Resources stocks made up 62 per cent of the top performers. This is up from 40 per cent in FY19 but lower than its FY18 proportion of 78 per cent.

The health and tech sectors had less winners this year. While last year they accounted for 31 and 19 spots respectively, this year they accounted for just 10 and 8 respectively.

Rounding out the list were four in the communications sector, two in consumer staples, seven in consumer discretionary goods, four in energy, two in financials and one in industrial.

The 10+ baggers

The top six best performing stocks all made gains of over 1,000 per cent. Four of these were in resources and the other two were in health. This is better than the previous two fiscal years, with FY18 only producing three 10+ baggers, while FY19 had none.

Taking top spot was former vanadium play Auteco Minerals (ASX:AUT), which has never looked back since buying a 1.5-million-ounce Canadian gold project called Pickle Crow in January.

If you invested $2,000 into this stock at the start of the financial year and sold at the end you would now have $64,000.

Second is Zoono Group (ASX:ZNO), which makes bug killing substances. While COVID-19 did indeed cause a spectacular lift in its sales, the run began the previous year with its work in the poultry industry as it battles swine flu.

Taking bronze place is Magmatic Resources (ASX:MAG), which has been the biggest winner of the East Lachlan porphyry copper-gold rush.

While it had been selling the story of its project for several months prior, it took a monster discovery from neighbouring Alkane Resources (ASX:ALK) to get investors excited.

But while Alkane has made the top 100, it is only in 77th spot while Magmatic is third. Even though many other neighbouring explorers also rallied, the only other to sustain momentum to make the top 100 is Alice Queen (ASX:AQX) at #96.

Rounding out the 10 baggers are:

• Race Oncology (ASX:RAC) off the back of clinical trial success for its anti-cancer drug as well as its future ambitions;
• Now billion-dollar gold explorer De Grey Mining (ASX:DEG), whose exploration success at its Hemi gold project speaks for itself and;
• Gold and base metals play Scorpion Minerals (ASX:SCN) with positive rock chip results in February and excitement about an upcoming drilling campaign.

Resources winners

Australian investors have been particularly excited about gold stocks since the gold price surpassed $2,000 in June last year. While gold had seen bull runs previously, such as in 2011, the prices in Aussie dollar terms this time around hit new records because of the weak Aussie dollar against the greenback.

While prices have been fluctuating in AUD terms –surpassing $2,700 when the AUD crashed to 57 US cents — they have been consistently rising in USD terms and are over 25 per cent higher in 12 months.

Plenty of other gold stocks made big discoveries, such as Africa-focused Predictive Discovery (ASX:PDI) and Musgrave Minerals (ASX:MGV).

Others have simply risen after notable investors bought in such as Riversgold (ASX:RGL) which took off when Tolga Kumova bought in.

But gold did not have a monopoly of the best performing resources ASX stocks. In 12th spot is Chalice Gold Mines (ASX:CHN), which does have gold projects, but its share price run was inspired by its Julimar nickel discovery.

Meanwhile, copper explorer Stavely Minerals (ASX:SVY) rocketed off the back of massive hits at its Victorian project, beginning with a 40 per cent hit last September which caused its share price to take off.

Health stock success stories

While Race Oncology (ASX:RAC) was the best performing ASX health stock and the only 10-bagger, others witnessed share price gains on clinical success.

One was Recce Pharmaceuticals (ASX:RCE) which targets so-called superbugs — bacteria strong enough to resist conventional antibiotics. Its successes this year included against gonorrhoea and Staphylococcus aureus — albeit at the pre-clinical stage.

The latter bacteria can cause sepsis, a common inflammation which can be life threatening and accounts for 2 per cent of hospitalisations and 17 per cent of hospital deaths.

Opthea (ASX:OPT) passed two separate stage II clinical trials against wet-aged related macular degeneration (wet-AMD) and diabetic macular edema (DME). Both eye diseases cause blindness as a consequence of fluid leakage at the back of the eye.

While wet-AMD is a far larger market, the company wants to proceed to stage III for both of the treatments and may even target other eye diseases.

Dimerix (ASX: DXB) is expecting results for two studies of its drug against diabetic kidney disease and focal segmental glomerulosclerosis (FSGS) in July.

But investors have also been excited about the use of its drug in a global COVID-19 treatment study.

Best performing tech plays

Once upon a time communications tech stock Harvest Technology Group (ASX:HTG) was focused purely on shark detection.

But it expanded its sphere into remote communications more broadly and it has paid off with contract wins and rising revenue. Harvest is the best performing ASX stock in this sector having surged over 700 per cent.

Just nudging into the “best performing ASX stocks” list on the last day was wireless technology company Etherstack (ASX:ESK) off the back of a solid rise on June 30. The catalyst was a network partnership deal with global communications giant Samsung.

Another latecomer is battery play Novonix (ASX:NVX). Its tech could reduce the cost of lithium-ion batteries and it has edged closer to commercialisation in recent weeks.

Other winners include logistics software stock Getswift (ASX:GSW) and accounts receivable software IODM (ASX:IOD).

Energy winners

The majority of ASX energy stocks are focused on oil and gas and they have witnessed a tough 2020 due to the collapse of oil prices.

But while Strike Energy (ASX:STX) is off highs seen late last year it has still more than tripled in 12 months following its discovery at West Erregulla with Warrego Energy (ASX:WGO).

This project shattered expectations when it flowed a stunning 69 million cubic feet of gas per day (MMcfd) from its primary target Kingia Sandstone.

The best performing ASX energy stock was Queensland-focused micro-cap Bounty Oil & Gas (ASX:BUY), which is now up 325 per cent to 1.7c.

The company has a 2 per cent stake in the Naccowlah Block in Queensland, where operator Santos (ASX:STO) has drilled eight wells in 2020, six of which have been cased for oil production and are awaiting tie-in to the production system.

While Bounty only has a small stake in Naccowlah, it still generated $594,000 in revenue in the March 2020 quarter.

Financial winners

Only two of the 100 best performing ASX stocks were financial stocks but both have their own unique stories.

One is Australian Ethical Investment (ASX:AEF), which was one of the first movers into ethical investing. The last 12 months were particularly successful as members and funds under management both increased.

Low-cost broker SelfWealth (ASX:SFW) had a good year too, first because of increasing awareness of alternatives to expensive retail brokers and second, COVID-19 causing cash-hungry people to give share trading a go.

Communications winners

There were four communications stocks on the best performing ASX stocks list.

The best performing is esports play MSM Corporation (ASX:MSM). It has rocketed 600 per cent over the financial year because of partnership wins and COVID-19 lockdown boredom.

Digital tech agency Neccentric (ASX:NCL) is another top performer, up 457 per cent.

The major catalyst has been prominent Malaysian entrepreneur Ganesh Kumar Bangah’s purchase of an 84 per cent stake in the company.

The other two winners were mobile entertainment play iSentric (ASX:ICU) and advertising platform XTD (ASX:XTD).

The winners with consumers

Most of the remaining winners were consumer-focused.

Retailers made up a high proportion of these and included Temple & Webster (ASX:TPW), The Reject Shop (ASX:TRS) and Kogan (ASX:KGN).

Niche product companies like electric scooter seller VMoto (ASX:VMT) and health supplements play Holista Colltech (ASX:HCT) have also done well.

Holista’s rise only happened as COVID-19 broke out across China because it sold a hand sanitiser that had been shown to work against other coronaviruses. Like Zoono, it saw exponential demand for its product.

The top performing ASX consumer stock was Betmakers (ASX:BET) as it rolled out its betting technologies across the US market.

The catalyst for the opportunity was the liberalisation of US state laws preventing online betting.

The best performing industrials stock

Among industrials only Orbital Corp (ASX:OBL) made the 100 best performing ASX stocks.

Orbital is a drone propulsion system designer and manufacturer, specifically for military tactical drones which undertake surveillance and intelligence work.

It rose over 160 per cent because of market demand in the defence sector.

Orbital began the last financial year already counting Boeing subsidiary Insitu a client and in recent months it won contracts with the Singapore defence forces and is anticipating an additional customer by years’ end.

At Stockhead, we tell it like it is. While Dimerix, De Grey Mining and Orbital are Stockhead advertisers, they did not sponsor this article. 

This story does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.

share

• 
• 
• 
• 

Link copied to
clipboard

SUBSCRIBE

Get the latest Stockhead news delivered free to your inbox.

Name*

Email*

Hidden

Email Lists

Morning Update

Lunch Update

Market Close Update

Weekend Update

Spotlight

Comments

This field is for validation purposes and should be left unchanged.

It's free. Unsubscribe whenever you want.

By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.

You might be interested in

Trending

Health & Biotech

Tryptamine’s world-first psilocin based IV-infusion meets key objectives in phase 1b study

November 22, 2024 | Special Report

Trending

Health & Biotech

‘Moving ahead with vigour’: Rhythm raises $3.5m for 2025 cancer test launch

November 22, 2024 | Nadine McGrath

Trending

News

MoneyTalks: IML’s Lucas Goode on why Hipages should trade at 'a much higher multiple'

November 22, 2024 | Eddy Sunarto